Blood Pressure, White Matter Lesions and Medial Temporal Lobe Atrophy: Closing the Gap between Vascular Pathology and Alzheimer’s Disease?

Background: Vascular factors are recognized as important risk factors for Alzheimer’s disease, although it is unknown whether these factors directly lead to the typical degenerative pathology such as medial temporal lobe atrophy. We set out to investigate the relation between blood pressure and medial temporal lobe atrophy in patients with senile and presenile Alzheimer’s disease with or without white matter lesions. Methods: We determined the relation between blood pressure and pulse pressure and medial temporal lobe atrophy on MRI in 159 patients with Alzheimer’s disease, stratified on white matter lesions and age at onset of dementia. Results: There was a linear relation between systolic blood pressure and pulse pressure (both in tertiles) and the severity of medial temporal lobe atrophy (ptrend = 0.05 and ptrend 0.03, respectively). A significant relation was found between pulse pressure [β = 0.08 (95% CI: 0.00–0.15; p = 0.05) per 10 mm Hg] and (borderline significant) systolic blood pressure [β = 0.05 (95% CI: –0.01 to 0.11; p = 0.1) per 10 mm Hg] and medial temporal lobe atrophy. White matter lesions and age-stratified analysis revealed a significant association between systolic blood pressure and pulse pressure and medial temporal lobe atrophy, only in the subsample with white matter lesions and in the subsample with a senile onset of dementia. The relations were independent of severity of dementia and diabetes mellitus. Conclusions: Systolic blood pressure and pulse pressure are associated with medial temporal lobe atrophy in Alzheimer’s disease, especially in the presence of white matter lesions and in patients with a late onset of dementia. Our finding may be another step in providing a rationale on how vascular factors could ultimately result in Alzheimer’s disease.

[1]  Philip Scheltens,et al.  Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment , 2004, Neurology.

[2]  Frederik Barkhof,et al.  White matter lesions and hippocampal atrophy in Alzheimer’s disease , 2004, Neurology.

[3]  P. Scheltens,et al.  Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.

[4]  B. Siesjö,et al.  The density and distribution of ischemic brain injury in the rat following 2–10 min of forebrain ischemia , 2004, Acta Neuropathologica.

[5]  I. Skoog Highs and lows of blood pressure: a cause of Alzheimer's disease? , 2003, The Lancet Neurology.

[6]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[7]  L. Csiba,et al.  Subcortical features and cognitive performance in Hungarian cerebrovascular outpatients , 2002, Journal of the Neurological Sciences.

[8]  M. Albert,et al.  MRI measures of entorhinal cortex vs hippocampus in preclinical AD , 2002, Neurology.

[9]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[10]  P. Scheltens,et al.  Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.

[11]  L. Launer Demonstrating the case that AD is a vascular disease: epidemiologic evidence , 2002, Ageing Research Reviews.

[12]  K. Meguro,et al.  Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project , 2002, Neuroradiology.

[13]  D. Bennett,et al.  MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease☆ ☆ This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. , 2001, Neurobiology of Aging.

[14]  P. Luiten,et al.  Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.

[15]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[16]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[17]  A. Folsom,et al.  Cardiovascular risk factors and cognitive decline in middle-aged adults , 2001, Neurology.

[18]  Michael G. Hennerici,et al.  Assessment of gait in subcortical vascular encephalopathy by computerized analysis: a cross-sectional and longitudinal study , 2000, Journal of Neurology.

[19]  P Julin,et al.  Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[20]  M. Mishkin,et al.  Developmental amnesia associated with early hypoxic-ischaemic injury. , 2000, Brain : a journal of neurology.

[21]  W. Markesbery,et al.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆ , 2000, Neurobiology of Aging.

[22]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[23]  Philip Scheltens,et al.  Visual assessment of medial temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry , 1999, Psychiatry Research: Neuroimaging.

[24]  A. Pfeffer,et al.  Magnetic Resonance Imaging-Based Hippocampal Volumetry in Patients with Dementia of the Alzheimer Type , 1999, Dementia and Geriatric Cognitive Disorders.

[25]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[26]  Cees Jonker,et al.  Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.

[27]  D. Carmelli,et al.  Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. , 1998, Stroke.

[28]  J. Wegiel,et al.  Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease , 1998, Brain Research.

[29]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[30]  R. D'Agostino,et al.  NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study , 1997, Diabetes Care.

[31]  D. Levy,et al.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.

[32]  A. Hofman,et al.  Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .

[33]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[34]  E. Ringelstein,et al.  Hyperinsulinism and cerebral microangiopathy. , 1996, Stroke.

[35]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[36]  D. Sparks,et al.  Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.

[37]  M. Raskind,et al.  Is Early‐Onset Alzheimer Disease a Distinct Subgroup Within the Alzheimer Disease Population? , 1995, Alzheimer disease and associated disorders.

[38]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[39]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.

[40]  K. Blennow,et al.  White‐matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors , 1991, Acta neurologica Scandinavica.

[41]  W. Jagust,et al.  Alzheimer's disease. Age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. , 1990, Archives of neurology.

[42]  J. Haxby,et al.  NIH conference. Alzheimer disease: clinical and biological heterogeneity. , 1988, Annals of internal medicine.

[43]  L. Barclay,et al.  Urinary and gait disturbances as markers for early multi-infarct dementia. , 1987, Stroke.

[44]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.